Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Pharmaron Beijing Co., Ltd. Class H ( (HK:3759) ) has shared an update.
Pharmaron Beijing Co., Ltd. announced the resignation of Mr. Hu Baifeng from his role as a non-executive director and member of the strategy committee. This change is due to the reallocation of Mr. Hu’s primary work responsibilities, which may impact the company’s strategic direction and governance structure.
More about Pharmaron Beijing Co., Ltd. Class H
Pharmaron Beijing Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the pharmaceutical industry. The company is listed on the Hong Kong Stock Exchange and focuses on providing a range of services related to drug research and development.
YTD Price Performance: -11.11%
Average Trading Volume: 1,531
Technical Sentiment Signal: Buy
Current Market Cap: €4.52B
For a thorough assessment of 3759 stock, go to TipRanks’ Stock Analysis page.